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Background: Study representativeness is a major concern for generalizations from trials. The extent of
the problem varies with study design and context. There is a strong emphasis on developing in-
terventions to help people remain in the work force despite mental illness. We need to know if results
from upcoming trials in this area are valid for those that later might receive the services.
Method: The AWaC trial was a multicenter RCT conducted at six different treatment centers (n ¼ 1193).
After the trial was over, the centers were upheld and run as ordinary services. At that time, we surveyed
80 ordinary service users with the same baseline questionnaire as used in the trial, and compared them
with those who participated in the trial.
Results: There were a higher proportion of people with the highest level of education (4 years or more at
university/college) in the post-trial comparison sample. This sample also reported to be “dissatisﬁed”
with their job more often, but rated their chances for return to work as “bad” less often than the ordinary
trial participants. No further signiﬁcant differences between the two samples in any of the other edu-
cation categories, or for any of the other demographic, health or work related comparisons were found.
Discussion: Participation bias is likely to depend on study context, but in the setting of a trial to help
improve work participation among people who struggle with common mental disorders, the trial par-
ticipants were overall very similar to those who sought the same services as ordinary practice.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Running a sound clinical trial is demanding, but implementation
of results in the wider population present numerous layers of
challenges. Trials commonly employ strict inclusion and exclusion
criteria to maintain experimental control and secure internal val-
idity [1]. Furthermore, participation in trials is based on informed
consent, and sub-sections of the population might be more or less
inclined to participate [2]. Participant selection and bias may arise
from criteria deﬁnitions and selective participation, and determine
generalizability of trial results outside the study sample [3,4].
For clinical trials in mental health, researchers have tried to
quantify this problem by assessing ordinary help-seekers withtal Health, Norwegian Insti-
rway
d).
Inc. This is an open access article ucommon study inclusion criteria. Of 346 patients with depression,
Zimmermann et al. found that only 1/6 would qualify for inclusion
in antidepressant efﬁcacy trials employing common criteria [5]. The
eligible population also differed from the non-eligible on de-
mographic, clinical and psychological proﬁles [6]. In a study of
actual trial recruitment, 7 out of 8 who volunteered, were turned
away due to pre-deﬁned criteria for study inclusion [7]. In a Dutch
study comparing participants in RCT's for major depressive disor-
der to patients attending ordinary care, the trial participants were
much more likely to be employed [8].
The core question of whether results from trials can be gener-
alized to a larger population does not seem to converge to one
general conclusion, but vary with the context of the trial. Some
studies argue that their trial results can represent real-life effects
outside the trial settings [1,9], whereas others prompt careful
consideration of generalizability [5,6,10,11].
Sickness absence and long-term work disability is a major issue
in occupational medicine, and we ﬁnd it is likely that the number ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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from mental illness will increase. In a recent pragmatic trial in this
context [12], we deﬁned exclusion/inclusion to allow recruitment
of participants who also would be likely to seek the intervention
outside the trial. In this paper, we examined if we were successful,
and hypothesised that the participants in our large multi-center
RCT did not differ substantially from those who attended the
same services outside the setting of a trial.
2. Methods
2.1. Context
The context of the AWaC-trial, from which these data were
generated (pre-trial registration details at ClinicalTrials.gov, regis-
tration number: NCT01146730) can be found in the main effect
study and its protocol [12]. In short, the trial tested the effectiveness
of the At Work and Coping intervention (AWaC) vs. usual care in
helping people who struggle with work participation due tomild to
moderate common mental illnesses participate in working life.
2.2. Study samples
This analysis is a comparison of a trial sample and a post-trial
comparison sample.
2.3. Trial sample
Trial participants were mainly recruited through referrals from
the Norwegian Welfare and Labor Administration, GPs and self-
referrals. The main inclusion criterion was that common mental
disorder was seen as the main reason why the person struggled
with work participation. The accepted age span was 18e60 years,
and potential participants had to express a motivation to return to/
stay at work. People were excluded if they reported other reasons
as the primary cause of work participation problems (e.g. somatic,
social, economic and work-related issues), no motivation/desire to
work, suffered from severe psychiatric disorders, had high suicide
risk or a current substance abuse problem, or was engaged in
psychotherapy elsewhere already. Pregnant womenwere excluded,
as were people unable to read or write in Norwegian.
Potential participants were informed about the project, and
screened for inclusion and exclusion criteria at the centers. Eligible
and willing participants signed the informed consent and
completed the baseline questionnaire. After random allocation,
participants were written about the outcome and the intervention
group were given a date for their ﬁrst session.
1416 potential participants were referred and considered for
inclusion. Of these, 197 did not fulﬁll the inclusion criteria, 17 did
not consent to participate, and 9 withdrew their consent and
required data deletion (2 from the intervention group and 7 from
the control group). In total, 1193 participants entered the trial and
were randomized.
2.4. Post-trial comparison sample
The sub sample of 80 personswas recruited after the completion
of the trial, and we obtained speciﬁc ethical approval for this data
collection. The datawere collected at the 6 centers that were part of
the multicenter trial in June 2012, when the centers no longer
recruited or evaluated potential patients for trial inclusion, or had
trial participants in treatment. New cases enrolled at the centers
over a period of onemonthwere invited to participate. Like the trial
participants, they came to the centers after referrals from the
Norwegian Welfare and Labor Administration, their GP, self-referrals or through other channels. We do not have the exact ﬁg-
ures on how many attended the centers during June 2013, but the
ﬁnal n of 80 exceeded the average number included in the trial per
month (total n ¼ 1193 included over a period of 18 months equals
an average of 67 participants per month). Those who were willing
to participate in the post-trial sample, were asked to complete a
shortened version of the baseline questionnaire used in the trial.
2.5. Statistical comparisons
The aim of this study was to compare the trial participants with
those who found their way to the same treatment centers after the
trial was over. We did this by comparing the two samples in terms
of self-reported demographic characteristics and scores on key
health variables using chi-square tests for categorical variables and
t-tests for continuous variables.
2.6. Ethics
The trial and the post-trial comparison survey were both
approved by the regional committee for medical research and all
participants provided informed consent.
3. Results
There was no overall difference between the samples on any of
the variables. When examining single response levels separately
there was a higher proportion of people with the highest level of
education (5 years or more at university/college) in the post-trial
comparison sample. They also reported to be “dissatisﬁed” with
their job more often, but rated their chances for return to work as
“bad” less often than the ordinary trial participants. Beyond that,
there was no signiﬁcant difference between the two samples in any
of the other education categories, or for any of the other de-
mographic, health or work related comparisons (Table 1).
4. Discussion
The data supported the hypothesis that those who participated
in a pragmatic multicenter randomized controlled trial were
comparable to those who attended the same services outside the
context of a trial in terms of self-reported health and demographic
characteristics.
There are limitations to our study that should be considered.
There could of course be a common self-selection process in both
these samples, where those unwilling to participate in research at
all e both concerning the trial and the post-trial comparison e
share the same characteristics and health status. Anecdotal evi-
dence however suggested that disapproval against randomization
was an important hindrance to participation for individuals, but
also their referring doctors or case-managers.
By logic of multiple testing, one in twenty comparisons should
appear signiﬁcant despite no true underlying difference. Here, we
did a total of 35 comparisons, and found three statistical differences
between the samples when directly comparing individual scores on
a scale, despite no overall difference for those scales. Thus, even in
the presence of these statistically signiﬁcant differences between
the samples, we argue these are insufﬁcient to reject our initial
hypothesis of similar samples.
Anecdotally, the treatment centers reported increased referral
rates after the trial inclusion period, which resonates with the
higher number of participants in the post-trial comparison sample
compared to the average inclusion per month during the trial. In-
dividuals, case-managers and general practitioners could have been
skeptical to participation as trials are more uncommon in this
Table 1
Background characteristics, trial-participants and regular service users (post-trial comparison sample) compared in t-tests and chi-square tests for continuous and categorical
variables respectfully.
Variable Trial sample Post-trial comparison sample p-value F-statistic
(p-value)
(n ¼ 1193) (n ¼ 80)
Female (%) 67.25 63.75 0.519
Married (%) 31.23 33.75 0.640
Age (%) 0.28 (0.596)
<30 12.81 13.75 0.809
30e39 30.31 31.25 0.861
40e49 32.41 33.75 0.805
50þ 24.45 21.25 0.517
Education (%) 2.66 (0.103)
Primary 7.11 5.00 0.427
Senior high 32.08 30.00 0.700
University/College 1e4 yrs 36.02 26.25 0.080
University/College 5 þ yrs 19.23 35.00 0.001
Other 5.44 3.75 0.514
Self assessed health (%) 0.22 (0.643)
Good 37.27 40.00 0.625
Medium 45.98 43.75 0.698
Poor 15.91 15.00 0.829
Employed (%) 66.67 65.00 0.760
Job satisfactiona 1.70 (0.193)
Very dissatisﬁed 5.53 6.25 0.785
Dissatisﬁed 13.07 21.25 0.039
Neither satisﬁed nor dissatisﬁed 17.42 13.75 0.400
Satisﬁed 29.06 26.25 0.591
Very satisﬁed 10.05 10.00 0.988
Have no job 21.52 21.25 0.954
Return-to-work prospectsb 0.21 (0.650)
Very good 12.40 12.50 0.978
Good 15.00 18.75 0.365
Neither good nor bad 26.13 27.50 0.787
Bad 17.34 8.75 0.047
Very bad 13.65 18.75 0.203
Missing data 15.49 13.75 0.676
HADSc Anxiety (mean) 10.67 10.91 0.615
HADSc Depression (mean) 8.07 8.19 0.801
Subjective health complaintsd (mean) 11.78 11.36 0.467
p-values from chi-square test for dichotomous variables, and t-test for continuous variables.
Signiﬁcant differences (p < 0.05) between the samples in bold.
a “Everything considered, how satisﬁed are you with your current job?”
b Consider this statement: “I count on being back at work within a couple of weeks”.
c Hospital Anxiety and Depression Scale, 14 items (7 on anxiety and 7 on depression) scored on a four point ordinal scale (0e3). A score of 8 or above is regarded as a case-
deﬁning symptom level.
d SHC-29, list of 29 subjectively reported common health complaints, four response levels on an ordinal scale (0e3).
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believed the intervention would yield positive results and be
continued after the trial. By holding back their patients until after
the service was deﬁned as a research project, the GP's could avoid
their patient ending up in the control group.
An amassing body of observational studies place common
mental disorders as a prominent risk factor for adverse occupa-
tional outcomes across countries and welfare systems. We will
likely see more trials being conducted in this area in the years to
come, and evidence to support the representativeness of trials in
this context must follow. This problem is often overlooked and
more careful implementation of trial results, moving them from the
controlled to the pragmatic contexts, is needed. Our analysis con-
tributes as a single result for the AWaC -trial, and supports that the
trial results are valid for those who attend the service under normal
circumstances. In lack of evidence to the contrary, self-selection out
of trial participation might not be a major problem in this context.
This paper also demonstrates a low-cost approach to study repre-
sentativeness that other trials could include in protocols.Acknowledgments
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